Clinical Cardiology Alert – June 1, 2006
June 1, 2006
View Issues
-
Pharmacology Watch
The absorption of thyroxine is strongly influenced by stomach acidity, according to new study. -
Clinical Briefs in Primary Care Supplement
-
CRUSADE Study
Crusade (can rapid risk stratification of unstable Angina Patients Suppress Adverse Outcomes With Early Implementation Of The ACC/AHA Guidelines) is a large quality improvement initiative ... -
News About Clopidogrel
Overall, clopidogrel plus aspirin was not significantly more effective than aspirin alone in reducing the rate of myocardial infarction, stroke, or death from cardiovascular disease. -
Long-Term Fenofibrate and Ezetimibe
Long-term, 48-week co-administration of Fenofibrate plus Ezetimibe was well tolerated and more efficacious than Fenofibrate in patients with mixed hyperlipidemia. -
Status of ECG Q-Waves
The new Q-wave criteria may be too nonspecific, resulting in an inappropriately high number of false-positive results. -
Complications Associated With ICD Replacement
ICD generator replacement in patients with device advisories is associated with a substantial rate of complications, including death. -
Clinical Features of Arrhythmogenic Right Ventricular Dysplasia
The various identified defects in cell adhesion proteins in ARVD/C lead to the same clinical consequences.